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Abstract
Objective: Neonatal hearing screening programs in Flanders
and the Netherlands use Natus ALGO screening devices.
Since 2006 in Flanders and 2009 in the Netherlands, both
programs have replaced the older ALGO Portable devices
with the newer ALGO 3i devices. However, in both countries,
ALGO 3i devices have a significantly higher rate of referrals
than ALGO Portable devices. In Flanders, the refer rate
has more than doubled with the switch to ALGO 3i devices.
In the Netherlands, screening centers which used ALGO 3i
devices also showed a significant increase in referrals. In
both countries, the percentage of children diagnosed with
permanent hearing loss remained approximately the same.
Design: A technical comparison of both device types was
carried out to identify possible causes for the increase in re-
ferrals. The stimulus output of two ALGO Portable and three
ALGO 3i devices was recorded and analyzed for stimulus
level, spectral properties and stimulus irregularities. Results:
ALGO 3i devices stimulate at a peak level 4.6dB lower than
ALGO Portable devices, have a different stimulus spectrum
and show unexplained stimulus irregularities during 4% of
the stimulation time. Conclusions: A number of technical
differences were found between both device types which
could explain the increase in referrals.
Introduction
In most developed countries, neonatal hearing screenings
take place in the first weeks after birth to detect unilateral
and bilateral permanent hearing impairment of 40dB or more.
These screenings rely on objective measures such as Otoa-
coustic Emissions (OAEs), Auditory Brainstem Responses
(ABRs) or Auditory Steady State Responses (ASSRs) (Joint
Committee on Infant Hearing 2007).
In Flanders, a region of Belgium, a neonatal hearing
screening program was implemented in 1998 that consists
of two successive rounds of screening based on Automated
Auditory Brainstem Responses (AABRs), followed by a re-
ferral for further clinical evaluation on positive screening
outcomes in both rounds (Van Kerschaver et al. 2007). For
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Figure 1: Neonatal hearing screening results for Flanders.
Dashed lines: preliminary data. (Van Kerschaver
and Stappaerts 2008)
the screening, Natus ALGO Portable devices had been used
until the end of 2006 when they were superseded by Natus
ALGO 3i devices. Other than the integration of the ALGO
3i devices’ feature to synchronize patient screening results
with a central database, no change of screening procedure or
parameters took place during the switch to the new devices.
With about 2.3h of all screened children in Flanders, the
percentage of permanently hearing impaired children has
been more or less constant over the years (figure 1). The
percentage of children referred for further clinical evaluation
on the other hand has increased substantially with the switch
to the new ALGO 3i devices. Between 2005 and 2007, when
the switch to the new devices took place, the number of
children referred has increased from 3.1h to 7.6h of all
screened children and remained constant afterwards (Van
Kerschaver and Stappaerts 2008). This change corresponds
to a sixfold increase in false positives, mostly consisting of
children with slight temporary conductive hearing impair-
ments.
In the Netherlands, a general neonatal hearing screening
1
program organized by the National Institute for Public Health
and the Environment (RIVM) was introduced between 2002
and 2006. Newborns are screened in three successive rounds,
and are referred for further clinical evaluation on positive
screening outcomes in all three rounds. While the first two
rounds use transient-evoked OAEs, the third round is also
based on ABRs measured with ALGO Portable and later
ALGO 3i devices.
In 2009, the program in the Netherlands was evaluated
by the independent research institution Netherlands Organi-
zation for Applied Scientific Research (TNO). For children
without permanent hearing loss that took part in the third
round of screening, the number of referrals for the ALGO
Portable devices were 6.5% and 6.7% for screening organi-
zations that conducted the first two rounds at home or in a
screening center, respectively. For screening organizations
that switched to ALGO 3i devices, these numbers increased
to 9.5% and 12.7%, respectively (van der Ploeg and Rijpstra
2010, pages 19–20).
To evaluate the stimulus differences between the two used
device types, a technical comparison of ALGO Portable and
ALGO 3i devices has been worked out. The objectives of
this study were to check for (1) level differences, (2) spectral
differences, and (3) stimulus irregularities.
Materials and methods
Stimulation Five different neonatal hearing screening de-
vices were tested: two ALGO Portable devices and three
ALGO 3i devices.
The two ALGO Portable devices were provided by Kind
& Gezin, the organization responsible for the hearing screen-
ing program in Flanders. These devices are older neonatal
hearing screening devices that were used in the neonatal hear-
ing screening program in Flanders until 2006 when Kind &
Gezin made the switch to the newer ALGO 3i devices. The
devices stimulate with alternating polarity clicks at a fixed
click rate of 38Hz and at a specified stimulus intensity of
35dBnHL. A proprietary EEG pattern matching algorithm
is used to determine the presence of an ABR.
Kind & Gezin also provided three ALGO 3i devices that
are currently in use in their neonatal hearing screening pro-
gram. These are the most modern hand-held devices that are
currently sold by Natus for neonatal hearing screening pur-
poses. They stimulate with alternating polarity clicks at two
different click rates, which changes between 34 and 37Hz
every 20s, and at a specified stimulus intensity of 35dBnHL.
These devices use an EEG pattern matching algorithm simi-
lar to that in the ALGO Portable devices.
Recording Recordings were done in a sound booth, with
a measurement setup equivalent to that required by the Natus
ALGO 3i calibration procedure. Transducers were connected
to the ear caps which were placed on a flat plate adapter (plex-
iglas, 70×70×10mm, part of the Natus acoustic check kit)
on a B&K 4152 artificial ear (figure 2). ALGO Portable and
ALGO 3i devices use different ear caps and positions of the
transducers relative to the ear caps. While the transducers of
ALGO Portable devices connect to the short side of Natus
ALGO Portable ear couplers, the transducers of ALGO 3i
devices connect to the long side of Natus Valu-Pak earphones
(figure 2). The artificial ear was connected to a sound level
meter B&K 2260, which was used for all measurements in
this report. Stimulus level was determined in dBSPL(A) as
that was the measure used in the Natus calibration instruc-
tions for the ALGO 3i devices in the Natus acoustic check kit.
Additionally, measurements were carried out in dBpeSPL(A)
to account for the pulsatile character of stimulation and to al-
low for the comparison of stimulus level across device types
as click rates were different for ALGO Portable and ALGO
3i devices.
For time-domain and spectral analysis, the sound level me-
ter was connected to a measuring amplifier B&K 2610 with
a 22.4Hz high-pass which in turn was connected to an RME
Multiface II soundcard, with inputs and outputs at −10dBV.
Recordings were done on a laptop with Adobe Audition at
96kHz sample rate and 24 bit sample width. The stimulus
waveforms for both transducers on all devices were recorded
for one minute. Additionally, a recording of a B&K 4230
94dBSPL sound level calibrator was made to calibrate the
recording setup. All recordings were then analyzed in MAT-
LAB. For each recorded waveform, the individual clicks
were detected, their polarity was determined by the polarity
of the initial peak, they were sorted by polarity, inverted if
necessary, averaged and their power spectral density was
calculated.
Results
Level differences Stimulus levels of the ALGO Portable
and ALGO 3i devices were compared. Mean stimulus lev-
els were 59.2dBSPL(A) (SD = 0.5dB) and 55.6dBSPL(A)
(SD = 0.3dB) for the ALGO Portable and ALGO 3i de-
vices, respectively. For the amplitude of the stimulus clicks,
mean peak levels were 79.6dBpeSPL(A) (SD = 0.6dB) and
75.0dBpeSPL(A) (SD = 0.2dB) for the ALGO Portable and
ALGO 3i devices, respectively.
Spectral differences Click shapes and power spectral
densities of the ALGO Portable and the ALGO 3i devices
were compared (figure 3). Power spectral densities were
similar for both device types up to 4kHz, but differed for
higher frequencies. In comparison to the clicks of the ALGO
Portable devices where a broad energy peak occurred be-
tween 4.5 to 8.5kHz, the clicks of the ALGO 3i devices ex-
hibited a narrower high-frequency peak at about 7 to 9kHz.
Stimulus irregularities The recorded stimulus wave-
forms were visually inspected for any irregularities and ana-
lyzed regarding click rate and polarity. While the stimulus
waveforms of the ALGO Portable devices did not show devi-
ations from an alternating click train at 38Hz, the recordings
of the ALGO 3i devices showed stimulus irregularities. The
ALGO 3i devices use alternating polarity click trains that
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Figure 2: Recording setup as used for the ALGO Portable (left) and ALGO 3i (right) devices. ALGO transducers connected
to ear caps placed on the flat plate adapter mounted on the B&K 4152 artificial ear.
change click rate every 20s, and for all devices checked,
each of these click rate changes happened in an irregular
way. Each change was followed by three groups of stimula-
tion irregularities consisting of (1) shifted clicks, resulting in
distances between successive clicks that were neither corre-
sponding to 34 and 37Hz, and (2) click polarity inversions,
where clicks were of a different polarity than what would
have been expected from an alternating pattern. An example
can be seen in figure 4. Across all ALGO 3i devices, these
irregularities were present during 0.77s after each click rate
change, or approximately 4% of the stimulation time.
Discussion
Level differences As all of the tested devices had been
calibrated by Natus, the significant difference of 4.6dB be-
tween the stimulus peak level of the ALGO Portable and
ALGO 3i devices can only be explained by a different cali-
bration procedure of the manufacturer for the different device
types. The decrease in stimulus peak level with the ALGO
3i devices compared to the ALGO Portable devices would
result in an increased sensitivity, as evoked potentials would
show reduced amplitudes, increased latencies and different
overall response shapes. Next to the anticipated permanent
hearing impairments, this increased sensitivity would also
result in the additional detection of mild temporary con-
ductive hearing impairments as observed in Flanders (Van
Kerschaver and Stappaerts 2008).
Spectral differences The differences in click shape and
spectrum could be explained by the different types of trans-
ducers used by the ALGO Portable and ALGO 3i devices.
Besides the type of the transducer, the different position of
the transducers relative to the ear cap could also be a cause
of the observed shape and spectrum differences. The dif-
ferences in spectrum hint at a different excitation pattern
inside the cochlea. Hearing threshold levels determined with
ABRs correlate mainly with a stimulus frequency range of 2
to 4kHz (Gorga and Neely 2002), but ABRs near threshold
can also be evoked by frequencies as low as 400Hz (Don
and Eggermont 1978). As spectral differences are minimal
in this region, only limited effects on the sensitivity of the
screening are expected.
Stimulus irregularities The stimulus irregularities seen
during the click rate changes with the ALGO 3i devices
result in clicks with shifted positions and inverted polarities.
It is unknown to the authors whether the averaging in the
ABR recording and analysis system in the ALGO 3i devices
is synchronized with the irregular click positions or whether
the theoretical click positions are used. In the latter case,
the averaging of approximately 4% of the responses is not
synchronized with the stimulation, which would lead to an
increase in noise and therefore measurement time. As some
of the irregularities are stable over time, the averaging would
also result in a wrong response shape and would therefore
affect test sensitivity.
Conclusions
When compared to ALGO Portable devices, ALGO 3i de-
vices exhibit multiple differences with regards to stimulus
characteristics and presentation: (1) different stimulus peak
levels of ALGO Portable and ALGO 3i devices, (2) dif-
ferent stimulus waveforms caused by different transducers
and transducer positions, and (3) stimulus irregularities with
ALGO 3i devices.
As there is no data available that shows that the difference
in stimulus level, click rate and transducers between ALGO
Portable and ALGO 3i devices and the stimulus irregularities
during the transition between the different click rates in
ALGO 3i devices have no influence on the screening results
in neonates, a study directly comparing the performance of
both devices types in neonates is necessary.
In our opinion, the technical differences found between
ALGO Portable and ALGO 3i devices could explain the in-
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Figure 3: Click characteristics for the ALGO Portable (two
devices with in total four transducers) and the
ALGO 3i devices (three devices with in total six
transducers).
crease in referrals seen in both Flanders and the Netherlands.
As the number of children referred for further clinical evalu-
ation is crucial for the costs of a neonatal hearing screening
program, screening organization should put more emphasis
on the evaluation of the false positive rate of screening de-
vices, e. g. by comparing the results from multiple different
device types during pilot studies, even if the devices use the
same underlying physiological measurement such as ABRs
or OAEs.
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